Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:GUDCVE:ICCNYSE:LEAFBATS:WEED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGUDKnight TherapeuticsC$5.81-0.7%C$5.87C$5.09▼C$6.45C$587.68M0.567,861 shs8,767 shsICCICC LabsC$1.62-5.8%C$1.62C$0.87▼C$2.00C$223.64MN/A799,310 shs646,156 shsLEAFLeaf Group$8.49$8.47$2.48▼$9.50$305.91M2.13959,348 shsN/AWEEDRoundhill Cannabis ETF$8.96-29.5%$10.78$8.79▼$35.37$4.41M0.9810,015 shs4,713 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGUDKnight Therapeutics-0.68%-3.49%+0.35%-3.33%+7.00%ICCICC Labs0.00%0.00%0.00%0.00%0.00%LEAFLeaf Group0.00%0.00%0.00%0.00%0.00%WEEDRoundhill Cannabis ETF-1.87%-6.25%-17.17%-18.63%-71.68%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGUDKnight Therapeutics1.887 of 5 stars2.80.00.00.03.41.70.6ICCICC LabsN/AN/AN/AN/AN/AN/AN/AN/ALEAFLeaf GroupN/AN/AN/AN/AN/AN/AN/AN/AWEEDRoundhill Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGUDKnight Therapeutics 3.50Strong BuyC$7.1523.06% UpsideICCICC Labs 0.00N/AN/AN/ALEAFLeaf Group 0.00N/AN/AN/AWEEDRoundhill Cannabis ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest WEED, ICC, LEAF, and GUD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/9/2025GUDKnight TherapeuticsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetHold ➝ BuyC$6.503/25/2025GUDKnight TherapeuticsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuyC$6.25 ➝ C$7.45(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGUDKnight TherapeuticsC$348.70M1.69C$1.51 per share3.85C$7.65 per share0.76ICCICC LabsC$533.68K419.04C$0.06 per share28.42C$0.29 per share5.68LEAFLeaf Group$212.06M1.44$0.02 per share400.34$2.19 per share3.88WEEDRoundhill Cannabis ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGUDKnight Therapeutics-C$30.73M-C$0.30N/A∞N/A-8.81%-4.04%0.51%N/AICCICC LabsN/AC$0.0295.29∞N/AN/AN/AN/AN/ALEAFLeaf Group-$8.86MN/AN/A∞N/A-1.94%-7.40%-3.79%N/AWEEDRoundhill Cannabis ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGUDKnight TherapeuticsN/AN/AN/AN/AN/AICCICC LabsN/AN/AN/AN/AN/ALEAFLeaf GroupN/AN/AN/AN/AN/AWEEDRoundhill Cannabis ETFN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGUDKnight Therapeutics7.523.361.79ICCICC LabsN/A24.848.74LEAFLeaf Group0.011.651.65WEEDRoundhill Cannabis ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGUDKnight Therapeutics12.58%ICCICC LabsN/ALEAFLeaf Group70.80%WEEDRoundhill Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipGUDKnight Therapeutics45.62%ICCICC LabsN/ALEAFLeaf Group11.40%WEEDRoundhill Cannabis ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGUDKnight Therapeutics725101.15 millionN/ANot OptionableICCICC LabsN/A138.05 millionN/ANot OptionableLEAFLeaf Group36036.03 millionN/AOptionableWEEDRoundhill Cannabis ETFN/A375,000N/ANot OptionableWEED, ICC, LEAF, and GUD HeadlinesRecent News About These Companies7 Best Marijuana Stocks and ETFs to Buy in 2025May 12, 2025 | money.usnews.com6 Best-Performing ETFs of Last WeekApril 21, 2025 | zacks.comRoundhill COIN WeeklyPay ETF (COIW)April 3, 2025 | uk.investing.comBest & Worst ETF Zones of Q1March 31, 2025 | zacks.comWhen (WEED) Moves Investors should ListenJanuary 19, 2025 | news.stocktradersdaily.com(WEED) Pivots Trading Plans and Risk ControlsJanuary 9, 2025 | news.stocktradersdaily.comTop & Flop ETFs of 2024December 31, 2024 | zacks.com(WEED) Long Term Investment AnalysisDecember 19, 2024 | news.stocktradersdaily.com(WEED) Trading AdviceNovember 27, 2024 | news.stocktradersdaily.com(WEED) Investment AnalysisNovember 17, 2024 | news.stocktradersdaily.com(WEED) Investment ReportOctober 26, 2024 | news.stocktradersdaily.com(WEED) Trading SignalsOctober 4, 2024 | news.stocktradersdaily.comWEED Roundhill Cannabis ETFOctober 4, 2024 | seekingalpha.com(WEED) Trading ReportSeptember 24, 2024 | news.stocktradersdaily.comRoundhill ETF Trust Roundhill Small Cap 0DTE Covered Call Strategy ETF (BATS:RDTE) Quotes, Forecast and News SummarySeptember 20, 2024 | benzinga.comRoundhill Magnificent Seven ETF (NASDAQ:MAGS), Short Interest ReportSeptember 9, 2024 | benzinga.com$1B In 26 Days: This Marijuana Company Is Capitalizing On Ohio's Cannabis SurgeSeptember 7, 2024 | benzinga.comYBTC Sep 2024 43.000 put (YBTC240920P00043000)August 20, 2024 | finance.yahoo.comLong Term Trading Analysis for (WEED)August 19, 2024 | news.stocktradersdaily.comQDTE Aug 2024 42.000 put (QDTE240816P00042000)July 30, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeWEED, ICC, LEAF, and GUD Company DescriptionsKnight Therapeutics TSE:GUDC$5.81 -0.04 (-0.68%) As of 06/23/2025 04:00 PM EasternKnight Therapeutics Inc. develops, manufactures, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices worldwide. It offers Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute nausea and vomiting associated with emetogenic cancer chemotherapy; Fostamatinib for chronic immune thrombocytopenia; Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Trelstar for advanced prostate cancer; Vidaza for myelodysplastic syndrome; Abraxane for metastatic pancreatic cancer; Halaven for metastatic breast cancer and soft tissue sarcoma; and Lenvima for advanced renal cell cancer and for differentiated thyroid cancer and unresectable hepatocellular carcinoma. The company provides Ladecvina for multiple myeloma and myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix for metastatic prostate cancer; Karfib for relapsed or refractory multiple myeloma; Leprid for advanced prostate cancer; Rembre for chronic myeloid leukemia; Palbocil for breast cancer; Ambisome and Cresemba for fungal infection; Impavido for leishmaniasis; Dolufevir for HIV infection; Exelon for dementia; and Ibsrela for irritable bowel syndrome with constipation. In addition, it offers Salofalk for ulcerative colitis; Ursofalk for biliary cirrhosis; Imvexxy for moderate to severe dyspareunia; Bijuva for vasomotor symptoms; Fibridoner for idiopathic pulmonary fibrosis; Toliscrin DPI for pseudomonas aeruginosa lung infection; Toliscrin 1-2 for severe acute or resistant chronic infections; and Tobradosa Haler for chronic lung infections. Further, it finances other life science companies; and invests in life sciences venture capital funds. The company was incorporated in 2013 and is headquartered in Montreal, Canada.ICC Labs CVE:ICCC$1.62 -0.10 (-5.81%) As of 11/26/2018ICC Labs Inc., through its subsidiaries, produces and sells cannabis in Uruguay. It offers recreational cannabis, medicinal cannabis, cannabinoid extracts, and by-products for medicinal, recreational, and industrial use, as well as industrial hemp. The company is headquartered in Vancouver, Canada.Leaf Group NYSE:LEAFLeaf Group Ltd., together with its subsidiaries, operates as a diversified consumer internet company worldwide. It operates in two segments, Marketplaces and Media. The Marketplaces segment offers Society6.com, which provides artists with an online commerce platform to feature and sell their original art and designs on consumer products in the wall art, home décor, and tech and apparel accessories categories. It also provides SaatchiArt.com and its related art fair event brand, which is an online art gallery where a global community of artists exhibit and sell their original artwork directly to consumers. The Media segment offers Well+Good, a health and wellness media brand that offers journalistic approach to content; and Livestrong.com, a destination and action-oriented community, as well as mobile applications, such as MyPlate that monitor users' health, fitness, and life achievements. This segment also provides Hunker, a home design media site for enabling first-time homeowners enhance their homes with practical solutions, home tours, and design advice for people; and Only In Your State, a US-focused local attractions and review site, which highlights small businesses, hidden gems, and natural wonders for the audience. In addition, this segment offers content creation, traffic source, mobile application, and monetization services; and develops partner sites. It sells its products through wholesale channels to trade and hospitality clients, as well as through retail distribution partners. The company was formerly known as Demand Media, Inc. and changed its name to Leaf Group Ltd. in November 2016. Leaf Group Ltd. was incorporated in 2006 and is headquartered in Santa Monica, California.Roundhill Cannabis ETF BATS:WEED$8.96 -3.74 (-29.46%) Closing price 06/23/2025 03:59 PM EasternExtended Trading$8.95 -0.01 (-0.15%) As of 06/23/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Roundhill Cannabis ETF (WEED) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of equities and total return swaps that provide exposure to the global cannabis and hemp ecosystem. WEED was launched on Apr 20, 2022 and is managed by Roundhill. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
